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ABSTRACT 
Purpose: Exercise-induced muscle-damage (EIMD) has recently been shown to increase heat strain during 
exercise-heat-stress (HS), and represents a risk factor for exertional heat illness (EHI).  We hypothesised that 
a repeated-bout of EIMD blunts the increase in rectal temperature (Tre) during subsequent endurance exercise 
in the heat.  Methods: Sixteen non-heat-acclimated males were randomly allocated to EIMD (n=9) or 
control (CON, n=7).  EIMD performed a downhill running treatment at -10% gradient for 60 min at 65% V
.
O2max in 20C, 40% RH.  CON participants performed the same treatment but at +1% gradient.  Following 
treatment, participants rested for 30 min, then performed HS (+1% gradient running for 40 min at 65% V
.
O2max in 33C, 50% RH) during which thermoregulatory measures were assessed.  Both groups repeated the 
treatment and subsequent HS 14-days later.  Isometric quadriceps strength was assessed at baseline, and 48-h 
post treatment.  Results: The decrease in leg strength 48-h post EIMD trial 1 (-7.5%), was absent 48-h post 
EIMD trial 2 (+2.9%) demonstrating a repeated-bout-effect.  Final Tre during HS was lower following EIMD 
trial 2 (39.25 ± 0.47 ºC) compared with EIMD trial 1 (39.59 ± 0.49 ºC, P< 0.01), with CON showing no 
difference.  Thermal sensation and the Tre threshold for sweating onset were also lower during HS on EIMD 
trial 2.  Conclusion: The repeated-bout-effect blunted the increase in heat strain during HS conducted after 
EIMD.  Incorporating a muscle-damaging bout into training could be a strategy to reduce the risk of EHI and 
improve endurance performance in individuals undertaking heavy exercise with an eccentric component in 
the heat.  
 
KEYWORDS: Thermoregulation; eccentric; inflammation; muscle-injury; hyperthermia; cross-adaptation, 
heat-illness, heat stroke 
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INTRODUCTION   
Exercising in hot conditions poses one of the greatest challenges to homeostasis of the human body 
(Armstrong et al. 2007; Sawka et al. 2011).  If heat production during exercise is not effectively dissipated, 
core body temperature can rise to dangerous levels, thereby placing the individual at risk of developing 
exertional heat-illness (EHI) (Armstrong et al. 2007), or the more serious, and potentially fatal condition of 
exertional heat stroke (EHS) (Casa et al. 2012; Sawka et al. 2011).  In addition to exercising in hot and 
humid environments, a number of risk factors for EHI/EHS have been identified, including; inappropriate 
clothing, inadequate heat-acclimation, high body mass index, poor physical fitness, dehydration, and 
underlying medical conditions (Armstrong et al. 2007; Epstein et al. 1999; Rav-Acha et al. 2004; Sawka et 
al. 2011).  Other potential risk factors, which are less well supported include disruption of sleep, and the 
circulating inflammatory response (Bouchama 1995; Lim and Mackinnon 2006; Moore et al. 2013; Shephard 
and Shek 1999). 
 
Highly motivated, well trained athletes, who may ignore normal thermoregulatory behavioural cues, and 
military personnel, in whom evaporative cooling is limited due to their occupational clothing, and where 
exercise intensity is often externally regulated, are two groups who may be at particular risk of EHI/EHS 
(DeMartini et al. 2014).  A number of deaths in athletes and military personnel each year are attributed to 
EHS (Carter, III et al. 2005; Casa et al. 2012; Rav-Acha et al. 2004).   These groups regularly perform 
multiple bouts of heavy exercise, often within a short time span and in hot environmental conditions, and 
potentially involving an eccentric component (e.g. walking downhill/jumping/lunging etc.).  We (Fortes et al. 
2013), and others (Montain et al. 2000), have shown that prior exercise-induced muscle-damage (EIMD) 
increases heat strain during exercise-heat-stress conducted shortly after muscle damage.  For example, final 
rectal temperature (Tre) was 0.53°C higher during 40 min of moderate exercise-heat-stress conducted 30 min 
after 1-hour of EIMD, compared to identical exercise-heat-stress conducted 30 min after 1-hour of non-
muscle-damaging control exercise (Fortes et al. 2013).  This increased heat strain suggests that performing 
exercise with an eccentric component may represent an additional risk factor for EHI. 
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Clearly, it is of interest to investigate, and adopt strategies that may reduce the risk of EHI.  It is plausible 
that reducing the degree of muscle damage encountered will also lessen the degree of heat strain 
encountered.  One obvious, but unexplored avenue of investigation is the well-known repeated bout effect of 
muscle-damaging exercise, where a single session of eccentric exercise induces adaptations resulting in less 
evidence of damage when the exercise bout is repeated (Clarkson et al. 1992; Clarkson and Hubal 2002; 
McHugh et al. 1999).  The mechanism to explain this repeated bout effect is not fully understood, though 
likely involves neural, cellular and mechanical mechanisms (Clarkson et al. 1992; Clarkson and Hubal 2002; 
McHugh et al. 1999).   In our previous study (Fortes et al. 2013), increased circulating interleukin (IL)-6 
concentration following EIMD was associated with increased heat strain during subsequent exercise heat 
stress, a pertinent finding due to a potential inflammatory role in the aetiology of EHI/EHS (Bouchama 1995; 
Lim and Mackinnon 2006; Shephard and Shek 1999).  A dampening of the inflammatory response is one 
proposed explanation for the repeated bout effect (Pizza et al. 1996), and given that there is some evidence 
that circulating IL-6 concentration is reduced following a second, repeated bout of EIMD compared with the 
first bout (Smith et al. 2007) this may provide a mechanism for a potential beneficial repeated bout effect in 
reducing heat strain. 
 
With this in mind, the aim of this study was to investigate the influence of the EIMD repeated-bout-effect 
upon heat strain during subsequent exercise in the heat.  To this end, we had non-heat-acclimated 
participants perform muscle-damaging exercise using a downhill running model, and then assessed heat 
strain during an exercise-heat-stress test conducted 30 min post EIMD to coincide with the circulating 
inflammatory response.  This procedure was then repeated 14 days later.  We hypothesised that the second 
(repeated) bout of EIMD would blunt the increase in Tre during subsequent exercise-heat-stress compared 
with the first EIMD trial.  In order to discount any potential temporary heat acclimation, or passage of time 
effects, a separate control group undertook all identical procedures, except that non-muscle damaging 
exercise was performed instead of EIMD. 
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ABBREVIATIONS: 
CON – Control group 
eHsp72 – Extracellular heat shock protein 72 
EIMD – Exercise-induced muscle damage 
HR – Heart rate 
HS – Exercise-heat-stress test 
Hsp – Heat shock protein 
IL - Interleukin 
Ṁ - Metabolic energy expenditure 
NBM – Nude body mass 
RER – Respiratory exchange ratio 
RH – Relative humidity 
RPE – Rating of perceived exertion 
TNF – Tumour necrosis factor 
Tre – Rectal core temperature 
Tsk – Skin temperature 
VO2max – Maximal oxygen uptake 
WURSS – Wisconsin upper respiratory symptom survey 
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METHODS 
Participants 
Sixteen healthy, physically-active males volunteered to participate in the study, giving fully-informed 
consent in writing. The study received local ethical approval and was conducted according to the standards 
required by the Declaration of Helsinki.  Characteristics of the participants were as follows: (Mean ± 
standard deviation): age, 21.9 ± 1.7 yr; nude body mass, 72.3 ± 7.5 kg; height, 176 ± 7 cm; body mass index, 
23.1 ± 1.9 kg∙m-2; body surface area, 1.88 ± 0.12 m2, and maximal oxygen uptake (VO2max) 59 ± 5 mL∙kg-
1∙min-1. Participants were excluded if they were heat-acclimated, or regularly undertook downhill running or 
eccentric exercise as part of their normal training.  Participants were non-smokers, and free from any known 
immune, cardiovascular or metabolic disease.  To further confirm participants were free from upper-
respiratory tract infections, on each of the 14 days preceding both main trials, participants completed an 
illness-specific questionnaire (WURSS-44) (Barrett et al. 2002).  No participants were taking any medication 
(e.g. non-steroidal anti-inflammatory drugs) or generic supplementation.  Participants were asked to refrain 
from exercise 72 hours prior to, and from alcohol and caffeine 24 hours prior to all exercise bouts.   
 
Study design 
Participants were randomised to one of two protocols, EIMD or CON.  Nine participants completed an 
exercise-heat-stress-test 30 min after a treatment of muscle damaging exercise (EIMD: running downhill on -
10% gradient) (trial 1). This protocol was repeated two weeks later (trial 2).  A separate control group (CON, 
n = 7) performed energy expenditure equivalent non-muscle-damaging exercise treatment (CON: running at 
+1% gradient), followed 30 min later by the exercise-heat-stress test, with the protocol repeated 14 days 
later.  Thermoregulatory measurements (Tre, skin temperature (Tsk), sweating rate), perceptual measures 
(thermal sensation, rating of perceived exertion), heart rate, and metabolic energy expenditure, were assessed 
throughout all heat stress tests.  Blood samples were collected at pre-treatment, pre, post and 1-hour post HS 
on all trials and assessed for circulating inflammatory markers IL-6, IL-10, and heat shock protein (Hsp) 72 
concentration.  Circulating extracellular (e)Hsp72 was measured as concentrations have been shown to 
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increase following EIMD (Peake et al. 2005), eHsp72 itself may also have direct pyrogenic effects 
(Pastukhov et al. 2003), and it provides an additional measure of the inflammatory response due to its 
immune-stimulating capability (Asea et al. 2000; Whitham and Fortes 2008).   Isometric leg strength of the 
quadriceps, and perceived muscle soreness were determined at baseline and 48-hours post trials to assess the 
degree of muscle damage.  There were no differences in anthropometric or fitness data between the groups.  
An overview of the study design is presented in Fig 1. 
***Insert Fig.1 here*** 
 
Experimental procedures 
Preliminary testing and familiarisation 
The VO2max for each participant was determined by a continuous maximal incremental exercise test to 
exhaustion performed on a motorised treadmill (HP Cosmos Mercury 4.0, Nussdorf-Traunstein, Germany) 
(Fortes et al. 2013).  Expired gas was analysed by an on-line breath-by-breath system (Cortex Metalyser 3B, 
Biophysik, Leipzig, Germany).  After this, the treadmill running speed which elicited 65 % VO2max running 
at +1 % gradient was obtained by interpolation of the running speed-VO2 relationship.  A running speed 
verification was then conducted and employed as the running speed for the treatment on the CON group, and 
for the heat stress test for both groups.  A subsequent verification was also performed on downhill running at 
-10 % gradient with expired gas analysed on a continuous basis, and with the running speed adjusted 
accordingly until 65 % VO2max was attained.  This downhill running verification took no more than 6 
minutes, and the verified running speed was used during treatment on those assigned to muscle-damaging 
(EIMD) trials.  Expired gas data were averaged every ten seconds over a period of two minutes during this 
process of verification.   All instrumentation and procedures used in the experimental trials were also 
presented to participants at this time.  Thirty minutes after this verification was completed, maximal 
isometric leg strength was measured to assess participants’ baseline quadriceps leg-strength within 7 days of 
the first experimental trial.  Diet diaries were provided to record all food consumed during the 24 hours prior 
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to, and during the first experimental trial, and participants were instructed to replicate this before and during 
the second trial 14 days later. 
 
Experimental trials 
On the day of each experimental trial participants reported to the laboratory (ambient temperature 20 °C and 
relative humidity (RH) 40 %) at 07:10 am having fasted overnight. Participants were provided fluids to 
consume (40 mL∙kg-1∙NBM∙d-1) in the prior 24-hour period to ensure they began exercise euhydrated.  This 
was verified by checking that urine-specific gravity (Atago Uricon-Ne refractometer, Atago Co., Ltd. Tokyo, 
Japan.) upon arrival was less than 1.028 (Armstrong et al. 2010).  Participants fasted condition was verified 
by a finger-prick blood sample analysed for glucose and ensuring the reading was <6 mg·dl-1 (ACCU-
CHECK Aviva, Roche, Basel, Switzerland). Participants’ nude body mass (NBM) was then measured on a 
digital platform scale accurate to the nearest 50 g (model 705, Seca, Hamburg, Germany).  A cereal bar 
equivalent to 8.4 kJ∙kg-1 NBM and water (5 ml∙kg-1 NBM) was subsequently provided to participants based 
on this body mass. At 08:15am, baseline NBM was measured, and a resting blood sample was taken before 
the participant fitted a rectal thermistor and heart rate monitor (Polar Electro, Kempele, Finland).  The 
participants also rated their perceived muscle soreness at this stage.  
 
Exercise trial treatment 
The exercise trial treatment (EIMD or CON) started at 08:30 am, with standardised clothes worn by 
participants (e.g. running shorts, socks and shoes).  Participants ran for 60 min at the individualised 
predetermined speed that reflected 65 % VO2max on either +1 % gradient (CON) or -10 % gradient (EIMD). 
Rectal core temperature and heart rate (HR) were assessed every 10 min, and 60 s expired gas samples were 
collected by Douglas bag method at 20 and 40 min of exercise, and analysed for VO2.  Water (2 mL∙kg-
1NBM) was provided throughout treatment every 15 min. 
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Exercise heat stress 
After the treatment, participants sat for 30 min in a temperature controlled environment (20 °C) during which 
skin thermistors were applied (Grant EUS-U, Cambridge, UK). Participants were provided with a 
standardised amount of fluids (2.5 mL∙kg-1NBM) during this time. A blood sample was collected and pre-
heat stress NBM was determined just before the participant entered an environmental chamber (Delta 
Environmental System, Chester, UK) which was kept at a dry bulb temperature of 33 °C, 50 % RH, and 0.2 
m∙s-1 face-on wind velocity.  Immediately upon entering the chamber, a ventilated capsule was fastened to 
the forearm (for local sweating rate).  Participants then began exercise-heat-stress (HS) by running without 
fluids, on a motorised treadmill at +1 % gradient for 40 min at the predetermined set running speed that 
reflected 65 % VO2max. Throughout HS, the following measurements were taken: local forearm sweating 
rate, HR, Tre, physiological strain index (Moran et al. 1998) and skin temperature (Tsk) continuously; rating 
of perceived exertion (RPE, Borg 6-20 scale (Borg 1982)) and thermal sensation (McGinnis 0-13 points 
(Hollies and Goldman 1977)) every 5 min; and 60 s expired gas samples by Douglas bag method (VO2) 
every 10 min of exercise. Immediately after HS, participants were removed from the chamber, seated, and a 
blood sample was taken after a standardised period of 3 min (post HS). Post HS NBM (following towelled 
drying) was also determined at this time. Water was provided to replace sweat losses encountered during HS. 
A further blood sample was taken 1-h post HS.   Participants were then provided with a standardised meal 
(3290 kJ), and fluids to consume until they came back to the laboratory 48-h later for assessment of leg 
strength and perceived muscle soreness.  Participants were required to refrain from any exercise, or ingesting 
caffeine or alcohol in this 48-h intervening period.  The participant left the laboratory and returned 14 days 
later to repeat the trial (trial 2). 
 
Measurements and instrumentation 
Assessment of muscle damage  
Isometric right-leg quadriceps strength was assessed on a dynamometer (HUMAC norm, CSMi, Stoughton, 
MA, USA).  Participants were sat upright and strapped in on their upper extremities to limit excess motion.  
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The chair was adjusted so that the pivot was located on the lateral epicondyle of their right leg.  A lever was 
applied to the right leg and adjusted so that the pad was located on the inferior part of the tibialis anterior.  
This lever was locked in at an angle of 70 ° leg extension.  A warm-up protocol consisted of six sub-maximal 
repetitions (two repetitions at 25 %, 50 % and 75 % of perceived effort) with a 30 s recovery between each 
repetition.  Following a 2 min rest period, participants were required to exert maximal isometric force against 
the lever pad.  Verbal encouragement was given throughout each repetition. Isometric leg strength of the 
quadriceps was determined by the peak torque elicited from four maximal 5s contractions (with a 90 s 
recovery between each).  A separate pilot study conducted within our laboratory showed that there was no 
learning effect for this test, and that peak torque determined from this test has a day-to-day co-efficient 
variation of 5.5 %.  Perceived leg muscle soreness was self-rated by participants on a seven-point validated 
Likert scale (Vickers 2001), whilst walking up and down the laboratory. The participant was blinded to the 
scores they had previously reported. 
 
Body temperatures 
Rectal core temperature was assessed using a standard flexible, sterile, disposable thermistor (Henleys 
Medical Supplies Ltd, Herts, UK) inserted 12 cm beyond the anal sphincter, with temperature recorded using 
a data logger (YSI model 4000A, YSI, Dayton, USA).  In both repeated trials participants used the same 
thermistor.  Insulated thermistors (Grant EUS-U, Cambridge, UK) were attached to the skin via surgical tape 
which conducted heat and allowed evaporation (Hypafix, BSN medical GmbH, Hamburg, Germany), and 
were used to measure Tsk at four sites on the left side of the body (on the chest at a point equi-distant to the 
acromion process and the nipple, the anterior mid-bicep, the anterior mid-thigh, and the lateral calf).  The 
amount of tape used was standardised both between and within participants.  Temperature data were 
registered using a portable data logger (Grant SQ2020, Cambridge, UK).  Mean Tsk was calculated using a 
four-site weighted equation (Ramanathan 1964).  
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Sweating responses 
Whole-body sweating rate was estimated from nude body mass losses during HS.  Local forearm sweating 
rate was measured by dew-point hygrometry.  Anhydrous compressed nitrogen was passed through a 5 cm2 
capsule placed on the lower arm ventral surface (half-way between the antecubital fossa and carpus), and 
connected to a hygrometry system (DS2000, Alpha Moisture System, UK).  Local forearm sweating rate was 
calculated using the difference in water content between effluent and influent air and the flow rate (1 L∙min-
1), and normalised for the skin surface area under the capsule (expressed in mg∙cm-2∙min-1).  Sweating 
threshold and sensitivity were calculated by plotting the individual relationship between local forearm 
sweating rate and Tre values.  A simple linear regression equation for the first 6 min of exercise was 
calculated, with the threshold Tre for active thermoregulatory sweating defined as the Tre at which local 
forearm sweating rate = 0.06 mg∙cm-2∙min-1 (Buettner 1959).  Sweating sensitivity during the exercise 
transient phase was calculated as the slope of this linear regression line. 
 
Rate of metabolic energy expenditure (Ṁ) 
Oxygen consumption (VO2) was calculated from 60 s expired air samples collected into a Douglas bag and 
analysed for O2 and CO2 concentrations by a paramagnetic and infrared gas analyser (Servomex 5200 
Multipurpose, Crowborough, UK), and volume (Harvard Apparatus, Edenbridge, UK).  Respiratory 
exchange ratio (RER) was calculated, and  Ṁ  was determined using VO2 (L∙min-1) and RER in the following 
equation (Nishi 1981): 
Ṁ (W) = VO2 (21166 [0.23 (RER) + 0.77])/60. 
 
Blood collection, handling and analysis 
Whole blood samples were collected by venepuncture from an antecubital fossa vein and gathered into two 
K2EDTA and one lithium-heparin vacutainer tubes (BD, Oxford, UK).  Haematocrit (capillary method in 
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triplicate) using a micro-haematocrit reader (Hawksley & Sons Ltd., Lancing, UK) and haemoglobin 
concentration using a photometer (Haemocue, Sheffield, UK) were both analysed immediately on 
heparinised whole blood in triplicate with plasma volume change calculated (Dill and Costill 1974).  The 
remaining whole blood was spun in a refrigerated centrifuge at 1500 g for 10 min, with the plasma aspirated, 
aliquoted into reaction tubes, and frozen at -80°C for subsequent analysis.  Circulating IL-6 and IL-10 
concentrations were assessed on EDTA derived plasma using commercially-available high-sensitivity 
ELISAs (Quantikine® HS IL-6, HS600B; Quantikine® HS IL-10, HS100C, R&D Systems Europe, 
Abingdon, UK).  Circulating eHsp72 concentration was also assessed by commercially available ELISA 
(Hsp72 EIA kit, ADI-EKS-700B, Enzo Life Sciences LTD, Farmingdale, USA).  Intra-assay co-efficient of 
variation for circulating IL-6, IL-10 and eHsp72 concentration was 3.2 %, 5 %, and 3 % respectively.  For all 
biochemical analyses, all participants’ samples were always assayed on the same plate. 
 
Statistical analysis 
A sample size calculation was performed (G*Power, 3.1.5) using mean and standard deviation Tre data from 
our previous study (Fortes et al. 2013). For a two-tailed test with alpha level set at 0.05, and power set at 0.8, 
it was deemed appropriate to recruit a minimum of 7 participants in each group to detect a meaningful 
difference in final Tre during subsequent exercise in the heat.  Due to recruitment randomisation, 9 
participants were recruited into the EIMD group, and 7 into CON.  All data were checked for normality and 
sphericity.  Data were analysed within condition (i.e. EIMD trial 1 vs trial 2), using two way repeated 
measures ANOVA or paired t-tests as appropriate. Bonferroni-adjusted paired t-test post-hoc procedures 
were used to determine within-subject differences. Pearson product moment correlation was also performed 
to assess the relationship between change in leg strength 48h after EIMD with change in Tre during HS.  All 
data were analysed using SPSS version 20 software (IBM, NY, USA).  Data are presented as means ± SD.  
Statistical significance was accepted as P < 0.05. 
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RESULTS 
Treatment responses 
The experimental model was successful in demonstrating a repeated bout effect of muscle damage, since the 
decrease in isometric leg strength 48h following EIMD trial 1 (-7.5 % vs baseline), was absent 48 h post 
EIMD 2 (+2.9 % vs baseline) (P < 0.01 versus trial 1, Fig 2a), and increases in perceived muscle soreness 
48-h post EIMD in trial 1, were blunted in trial 2 (P < 0.05, Fig 2c).  The control group did not demonstrate 
any differences in leg strength (P = 0.37, Fig 2b) or muscle soreness (P = 0.60, Fig 2d) between trial 1 and 
trial 2.   There were no differences between trials 1 and 2 in either EIMD or CON for ΔTre during treatment 
(EIMD trial 1, 1.84 ± 0.35, trial 2 = 1.77 ± 0.43 °C, P = 0.53; CON trial 1 = 1.36 ± 0.49, trial 2 = 1.48 ± 0.43 
°C, P = 0.42).    
*** Insert Fig. 2 here *** 
 
Exercise heat stress responses 
Rectal temperature, skin temperature and physiological strain index 
Rectal core and Tsk responses to HS are presented in Fig 3.  There were no significant differences in Tre and 
Tsk responses to HS between CON trial 1 and CON trial 2 (Figs 3b,3d, 3f), confirming that there was no 
temporary heat acclimation effect of the first HS test on the second HS test or passage of time effect on heat 
strain responses to HS.  All participants on EIMD had a lower final Tre during HS on EIMD trial 2 (39.25 ± 
0.47 ˚C) compared with EIMD trial 1 (39.59 ± 0.49 ˚C, P < 0.01, Fig 3a), with only two participants showing 
evidence of mild hyperthermia during HS on EIMD trial 2 (final Tre > 39.5 ˚C) compared with seven on 
EIMD trial 1. Physiological strain index was lower during HS on EIMD trial 2 (6.8 ± 2.8) compared with 
EIMD trial 1 (7.3 ± 3.1, P < 0.01). There was no significant difference in starting Tre between EIMD trials 1 
and 2 before HS, but Tre was significantly lower on EIMD trial 2 compared with EIMD trial 1 throughout HS 
(main effect of trial, F = 22.2, P < 0.01), with a trend for an interaction (F = 2.9, P = 0.09, Fig 3c).  The ΔTre 
during HS was also lower after EIMD trial 2 (1.61±0.33 ˚C) than trial 1 (1.81±0.40 ˚C, P<0.05) and the ΔTre 
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during HS correlated moderately with leg strength loss 48-h post EIMD (r = 0.46, P = 0.05).  There was no 
repeated bout effect on mean Tsk during HS following EIMD (P = 0.32), Fig 3e). 
*** Insert Fig. 3 here*** 
 
Sweating rate and plasma volume change 
Whole body sweating rate was not different between the EIMD trials during HS (EIMD trial 1 = 23.3 ± 5.0, 
EIMD trial 2 = 23.0 ± 7.6 mL·min-1, P = 0.89), but there was a tendency for a higher local sweating rate on 
EIMD trial 2 (F = 2.6, P = 0.08) during HS on EIMD trials (Fig 4a).  Although there was no difference in 
sweating sensitivity between EIMD trials during the initial transient exercise phase (P = 0.17), the threshold 
temperature for sweating onset was significantly lower on EIMD trial 2 than EIMD trial 1 (EIMD trial 1 = 
37.74 ± 0.16 ˚C, EIMD trial 2 = 37.58 ± 0.24 ˚C, P < 0.05; Fig 4b).  No differences were observed during HS 
for sweating rate, sweating onset, or sweating sensitivity between CON trial 1 and 2.  There was no effect on 
plasma volume change following HS on EIMD or CON trials. 
*** Insert Fig. 4 here *** 
 
Rate of metabolic energy expenditure, RER and HR  
There were no between-trial differences on EIMD for mean Ṁ (trial 1 =1045 ± 115, trial 2 =1030 ± 128 W, 
P=0.21), indicating no improvement in running economy between trials.  These metabolic rates equated to 
75 % ± 5 % and 74 % ± 6 % VO2max for EIMD trial 1 and trial 2 respectively, during HS.  No difference was 
observed in mean RER or HR between EIMD trial 1 and EIMD trial 2 during HS (RER: EIMD trial 1 = 0.88 
± 0.03, EIMD trial 2 = 0.88 ± 0.04, P = 0.80, HR EIMD trial 1 = 176 ± 14 beats·min-1, EIMD trial 2 = 175 ± 
12 beats·min-1, P = 0.54).   
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RPE and thermal sensation 
Thermal sensation and RPE data for EIMD are presented in Fig 5. Participants rated their thermal sensation 
lower throughout HS following EIMD trial 2 compared with trial 1 (main effect of trial, F = 6.5, P < 0.05, 
Fig 5a).  There was a trend (main effect of trial, F = 3.7, P = 0.09) for participants to rate their perceived 
exertion lower during HS following EIMD trial 2 compared with EIMD 1 (Fig 5b).  No differences were 
observed during HS for RPE or thermal sensation between CON trial 1 and 2. 
*** Insert Fig. 5 here *** 
 
Plasma IL-6 and IL-10, and eHsp72 
Circulating concentrations of IL-6, IL-10 and eHsp72 responses to EIMD are depicted in Fig 6.  There was 
no EIMD repeated bout effect on the inflammatory response between trial 1 and 2 for IL-6 (F = 2.3, P = 
0.11), IL-10 (F = 0.7, P = 0.45), or eHsp72 concentrations (F = 0.8, P = 0.45).  Similarly, there were no 
between trial effects on CON for IL-6 (F = 0.9, P = 0.44), IL-10 (F = 0.2, P = 0.73), or eHsp72 concentration 
(F = 2.2, P = 0.15). 
*** Insert Fig. 6 here *** 
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DISCUSSION 
We have recently shown that an acute bout of EIMD increases heat strain during subsequent exercise heat 
stress (HS), and thus, EIMD likely poses a risk factor for EHI (Fortes et al. 2013). The aim of the present 
study was to investigate if the well-known repeated bout effect for EIMD (Clarkson et al. 1992; McHugh et 
al. 1999) would blunt the increase in heat strain during subsequent exercise-heat-stress. In line with our 
hypothesis, heat strain was reduced (0.34 °C lower final Tre) during HS following the second EIMD bout, 
compared with the first bout. Furthermore, 7 of 9 participants showed evidence of mild hyperthermia (final 
Tre > 39.5 °C) during HS on EIMD trial 1 compared with only 2 of 9 participants during HS following EIMD 
trial 2.  In addition, we observed a lower temperature threshold for sweating onset, a lower thermal sensation 
and a lower physiological strain index during HS after the second EIMD bout.  This lessened heat strain 
during HS on the repeated EIMD trial was not due to temporary heat acclimation as a consequence of the 
first HS bout, nor due to passage of time effects, since no difference in heat strain was observed in the 
control group.  By blunting the increase in thermal strain during exercise-heat-stress, incorporating a muscle-
damaging bout into training could be used as a practical strategy to reduce the risk of EHI, and improve 
exercise performance, in individuals undertaking subsequent heavy exercise bouts with an eccentric 
component in the heat. 
 
Unaccustomed and/or heavy eccentric exercise is known to result in EIMD, and is characterised by 
decreased muscle strength, and increased muscle soreness in the days following EIMD (Clarkson et al. 1992; 
Clarkson and Hubal 2002).  We utilised a downhill running model to evoke moderate, realistic muscle 
damage, evidenced by significant decreases in leg strength (-7.5 %), and increases in muscle soreness 48-h 
post EIMD trial 1.  This degree of muscle damage is equivalent to experiencing ‘a light pain when 
walking’(Vickers 2001) and therefore likely reflects the degree of muscle damage that may be encountered 
by soldiers and athletes undergoing unaccustomed exercise with an eccentric component.  Research has 
consistently shown, that a prior muscle damaging bout produces a protective adaptation that results in lesser 
symptoms of EIMD when the muscle damaging bout is repeated (e.g. blunted losses of leg strength, and 
reductions in muscle soreness) (Byrnes et al. 1985; Clarkson et al. 1992; McHugh et al. 1999).  The success 
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of the repeated bout effect was demonstrated herein, since leg strength was restored to baseline levels, and 
muscle soreness was significantly reduced 48-h following the repeated bout of EIMD.   
 
Heat strain during HS was reduced following the second, repeated bout of EIMD compared with the first, 
with the ΔTre, and final Tre reduced 0.2 °C and 0.34 °C respectively during HS on EIMD trial 2 compared 
with trial 1.  The final Tre on EIMD trial 2 was similar to the final Tre observed in the control group during HS 
on both CON trials (Fig 3b), although we acknowledge that these groups were composed of different 
individuals, so are not directly comparable.  In our previous study (Fortes et al. 2013), final Tre was 0.53 °C 
higher during HS following EIMD compared to control non-muscle damaging exercise in a repeated 
measures design, whilst Montain et al (2000), also demonstrated ~0.3 °C greater body temperature during 
HS following muscle damaging exercise compared to control exercise.  It therefore appears that a prior bout 
of EIMD provides a significant degree of protection against the increased heat strain that EIMD elicits 
during subsequent exercise-heat-stress. We acknowledge the limitation that we did not establish a 
performance benefit due to the reduced heat strain but anticipate a delay in reaching a critical core 
temperature (purported to be ~40 °C (Gonzalez-Alonso et al. 1999)) after repeated EIMD.  Further research 
should investigate whether the observed reduction in thermal strain with repeated EIMD translates into a 
meaningful performance improvement. In this regard, its noteworthy that a similar reduction in final 
exercising Tre (-0.3 °C) during exercise-heat-stress after 5 d heat acclimation brought about a 14% 
improvement in endurance performance during exercise in the heat (Garrett et al. 2009). We can have added 
confidence in our findings, since a particular strength of the current study is that a comparable control group 
was used in order to discount confounding heat acclimation or passage of time effects.  Previous research has 
also shown no effect of a single prior heat stress bout on subsequent thermoregulatory responses during 
exercise heat stress conducted 14 days later (Barnett and Maughan 1993).  
 
The circulating IL-6 response to muscle damaging exercise has been shown to be higher compared with non-
muscle damaging exercise (Bruunsgaard et al. 1997), a finding supported by our previous study (Fortes et al. 
2013) and where the elevated circulating IL-6 concentration following EIMD correlated with the final Tre 
attained during subsequent HS.  An elevated circulating IL-6 prior to heat stress is significant, given a 
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potential involvement of the acute inflammatory response in the aetiology of EHI (Bouchama 1995; Lim and 
Mackinnon 2006; Shephard and Shek 1999; Walsh et al. 2011).  A “dampening” of the inflammatory 
response is one proposed explanation for the repeated bout effect (Pizza et al. 1996).  Indeed, a previous 
study has shown reduced pro-inflammatory cytokines (IL-6), and increased anti-inflammatory cytokines (IL-
10) in the 12 hours following a repeated bout of muscle damage evoked by downhill running (Smith et al. 
2007), although this finding is not supported by studies that have used different models of muscle damage 
(e.g. isokinetic knee extensor exercise (Croisier et al. 1999; Willoughby et al. 2003)).  We were therefore 
interested in whether the hypothesised reduction in heat strain could be accounted for by an altered 
circulating inflammatory response following EIMD.  However, we did not observe any difference in pro-
inflammatory IL-6 or anti-inflammatory IL-10 response either prior to, or after heat stress between the two 
EIMD bouts.  It should be noted that in the study by Smith et al., cytokine concentrations were averaged 
over the 12 hour period following EIMD, thereby not providing useful information on the kinetics of the 
early inflammatory response immediately following EIMD (Smith et al. 2007).  We also assessed eHsp72 
concentration, which has been shown to be elevated following downhill running (Peake et al. 2005), and is 
also known to act as a “danger signal” activating the immune system (Horowitz and Robinson 2007; 
Whitham and Fortes 2008) including IL-6 (Asea et al. 2000).  Furthermore, eHsp72 itself may have direct 
pyrogenic effects (Pastukhov et al. 2003).  Nevertheless, we did not observe a difference in circulating 
eHsp72 concentration between EIMD trials.  It is noteworthy however, that the circulating IL-6 and eHsp72 
responses prior to HS during EIMD trial 1 were modest when compared with more metabolically challenging 
activities such as marathon running (Fehrenbach et al. 2005; Nieman et al. 2001), and therefore provided 
little margin for dampened responses.   
 
Muscle damaging exercise increases steady state exercising VO2 following downhill running (Braun and 
Dutto 2003) and rodent models have shown decreased contraction economy in damaged muscle fibres 
(Warren, III et al. 1996).  One might therefore anticipate improved running economy during HS on the 
second EIMD trial.  However, this was not the case, since Ṁ during HS was similar on both EIMD trials.  
EIMD has also been shown to inhibit glycogen resynthesis (O'Reilly et al. 1987), yet altered metabolism is 
also an unlikely mechanism since RER was not different between EIMD trials.  Whilst there was no effect on 
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Tsk, we did observe a lower temperature threshold for sweating onset, and a lower thermal sensation during 
HS on the second EIMD bout.  The mechanism(s) for how a muscle-damaging bout of exercise 14 d earlier 
decreased the threshold Tre for sweating onset during HS following a repeated-bout of EIMD remains 
unclear. There may be shared pathways with the concept of cross-tolerance, where adaptations to one 
stressor confer protection via molecular, cellular and neural interactions to other forms of stressor (Horowitz 
2014; Horowitz and Robinson 2007).  This process is thought to be mediated, in part, by intra-cellular heat 
shock proteins (Hsp’s), and it has been suggested that acquired thermotolerance (the accumulation of 
protective Hsp’s within cells following heat exposure), and systemic adaptations to heat acclimation share a 
common pathway (Kuennen et al. 2011).  This may be pertinent since EIMD has been shown to increase 
Hsp72 and Hsp27 expression within muscle cells following EIMD (Paulsen et al. 2009; Thompson et al. 
2001), and that the changes we observed during HS on EIMD trial 2, reflect similar adaptations to that 
observed during heat acclimation (reduced exercising Tre, earlier sweating onset, reduced thermal sensation).  
Furthermore, a smaller intracellular heat shock response is shown in heat-intolerant military personnel 
(Moran et al. 2006).  We acknowledge a limitation of the current study is that we did not assess intra-cellular 
Hsp’s.  It is possible that increases in Hsp’s within muscle cells following the first EIMD bout confer some 
degree of heat acclimation evident 14 d later but future work is required to investigate this.  It remains to be 
shown whether muscle-damaging exercise provides cross-tolerance against other novel stressors.  
 
Non-heat-acclimated individuals undertaking heavy training bouts with an eccentric component in the heat 
are likely at increased risk of developing EHI (Fortes et al. 2013; Montain et al. 2000) e.g. athletes 
performing unaccustomed exercise, or soldiers running or walking across mountainous terrain. Considered 
alongside our present findings this work might help to explain, at least in part, why EHS in athletes, soldiers 
and labourers typically occurs in the first four days of unaccustomed heavy exertion in the heat (Armstrong 
et al. 2007; Cluver 1932). The present findings indicate that this risk can be mitigated by incorporating a 
bout of muscle-damaging exercise into the training regimen, prior to travel/deployment to hot environments 
but this requires further investigation. Further research should also investigate the duration of the 
demonstrated protective effect and confirm whether other models of eliciting EIMD, e.g. drop-jumps, have a 
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comparable protective effect to that shown here with downhill treadmill running, with the added practical 
benefit of allowing a large number of individuals to be treated at once.   
 
CONCLUSIONS 
The repeated-bout-effect blunted the increase in heat strain during exercise-heat-stress conducted after 
EIMD, as shown by reduced exercising Tre, reduced thermal sensation, and earlier sweating onset.  
Incorporating a muscle-damaging bout into training could be a strategy to reduce the risk of EHI and 
improve endurance performance in individuals undertaking heavy exercise with an eccentric component in 
the heat. 
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FIGURE LEGENDS 
Fig 1 Schematic of experimental procedures. EIMD, exercise induced muscle damage; CON, energy 
expenditure equivalent control exercise; HS, exercise heat stress; RH, relative humidity. † denotes blood 
sampling time points 
 
Fig 2 Markers of muscle damage (leg strength peak torque and muscle soreness) assessed 48-h after either 60 
min exercise-induced muscle damage (-10% gradient running at 65% VO2max, EIMD, triangles, n = 9) or 60 
min of control exercise (+1% gradient running at 65% VO2max, CON, circles, n = 7).  Trial 1 represents the 
first bout, trial 2 represents the repeated bout performed 14d later. Individual responses are shown, with 
mean data shown as solid black squares.  # P < 0.05, ##P < 0.01 vs trial 1  
 
Fig 3 Final rectal temperature (Tre, a and b), absolute rectal temperature (Tre, c and d) and mean skin 
temperature (Tsk, e and f) responses during exercise-heat-stress tests which involved running for 40 min at 
65% VO2max in 33°C, 50% RH conducted 30 min after treatment which involved either exercise-induced 
muscle damage (-10% gradient running, EIMD, triangles, n = 9) or control exercise (+1% gradient running, 
CON, circles, n = 7). Note: due to individual skin thermistors becoming detached during HS, Tsk data (figs e 
and f) are presented in those with a full data set (n = 7 EIMD, n = 6 CON).  Individual responses are shown 
for final Tre (a and b), with mean data shown as solid black squares (## P < 0.01 versus trial 1).  For panels c-
f, mean ± SD data are shown, with trial 1 representing the first bout (filled symbols), and trial 2 representing 
the repeated bout performed 14d later (open symbols). § Trial 2 significantly lower than trial 1 (main effect 
of trial, P < 0.05) 
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Fig 4 Local forearm sweating rate reported as a function of time (a), and as a function of rectal temperature 
(Tre, b) during exercise-heat-stress tests which involved running for 40 min at 65% VO2max in 33°C, 50% RH 
conducted 30 min after exercise-induced muscle damage (-10% gradient running, n = 9).  Trial 1 represents 
the first bout (filled triangles), trial 2 represents the repeated bout performed 14d later (open triangles). 
Values are means (±SD in fig a). # Significantly different Tre for sweating onset (P < 0.05) 
 
Fig 5 Thermal sensation (a), and rating of perceived exertion (RPE, b) during exercise-heat-stress tests which 
involved running for 40 min at 65% VO2max in 33°C, 50% RH conducted 30 min after exercise-induced 
muscle damage (-10% gradient running, n = 9). Trial 1 represents the first bout (filled triangles), trial 2 
represents the repeated bout performed 14d later (open triangles). § Trial 2 significantly lower than trial 1 
(main effect of trial, P < 0.05). Data are mean ± SD 
 
Fig 6 Plasma interleukin (IL)-6 (a), plasma IL-10 (b), and extracellular heat shock protein (Hsp) 72 (c) 
concentrations at baseline, pre, post and 1h-post exercise-heat stress (HS), which involved running for 40 
min at 65% VO2max in 33°C, 50% RH, conducted 30 min after exercise-induced muscle damage (-10% 
gradient running, n = 9). Trial 1 represents the first bout (filled triangles), trial 2 represents the repeated bout 
performed 14d later (open triangles). No significant effects. Data are mean ± SD 
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